In Parkinson's disease, subthalamic nucleus (STN) neurons burst fire with increased periodicity and synchrony. This may entail abnormal release of glutamate, the major source of which in STN is cortical afferents. Indeed, the cortico-subthalamic pathway is implicated in the emergence of excessive oscillations, which are reduced, as are symptoms, by dopamine-replacement therapy or deep brain stimulation (DBS) targeted to STN. Here we hypothesize that glutamatergic synapses in the STN may be differentially modulated by low-frequency stimulation (LFS) and highfrequency stimulation (HFS), the latter mimicking deep brain stimulation. Recordings of evoked and spontaneous excitatory post synaptic currents (EPSCs) were made from STN neurons in brain slices obtained from dopamine-intact and chronically dopamine-depleted adult rats. HFS had no significant effect on evoked (e) EPSC amplitude in dopamine-intact slices (104.4±8.0%) but depressed eEPSCs in dopamine-depleted slices (67.8±6.2%). Conversely, LFS potentiated eEPSCs in dopamine-intact slices (126.4±8.1%) but not in dopamine-depleted slices (106.7±10.0%). Analyses of paired-pulse ratio, coefficient of variation, and spontaneous EPSCs suggest that the depression and potentiation have a presynaptic locus of expression. These results indicate that the synaptic efficacy in dopamine-intact tissue is enhanced by LFS. Furthermore, the synaptic efficacy in dopamine-depleted tissue is depressed by HFS. Therefore the therapeutic effects of DBS in Parkinson's disease appear mediated, in part, by glutamatergic cortico-subthalamic synaptic depression and implicate dopamine-dependent increases in the weight of glutamate synapses, which would facilitate the transfer of pathological oscillations from the cortex.
presence of normal dopaminergic "drive," the activity of BG neurons is largely desynchronized. However, in idiopathic PD and its experimental models, neurons of the external globus pallidus (GP) and subthalamic nucleus (STN), amongst others in the BG, loose their independence and show increases in burst firing and synchronization (Filion and Tremblay, 1991; Bergman et al., 1994; Nini et al., 1995) . During the slow-wave activity prominent in sleep and general anesthesia, this pathological activity favors low-frequency oscillations (<2 Hz) that are synchronized to ongoing slow cortical rhythms (Magill et al., 2001; Mallet et al., 2008a) . During wakefulness or analogous brain states, this pathological activity favors oscillations at beta (15-30 Hz) frequencies (Brown et al., 2001; Sharott et al., 2005; Kühn et al., 2006; Mallet et al., 2008a,b) , which may underlie rigidity and bradykinesia (Levy et al., 2000; Eusebio et al., 2011) . Pathological beta oscillations and motor symptoms may be reversed by dopamine replacement therapy (Brown et al., 2001; Kühn et al., 2006) , or by lesions or high-frequency (>100 Hz) stimulation ("deep brain stimulation" or DBS) directed to STN (Bergman et al., 1994; Eusebio et al., 2011) .
Using an organotypic culture preparation, Plenz and Kitai (1999) proposed that the GP and STN constitute a central pacemaker responsible for oscillatory activity, at least at low frequencies (<3 Hz). However, this proposal has not been supported in vitro (Loucif et al., 2005) or in vivo (Magill et al., 2000 (Magill et al., , 2001 . Instead, these studies point to a critical role of the cortex and STN in sculpting BG neuronal activity through the glutamatergic "hyperdirect" cortico-subthalamic pathway (Fujimoto and Kita, 1993; Maurice et al., 1998; Nambu et al., 2000; Magill et al., 2001 Magill et al., , 2004 Sharott et al., 2005; Mallet et al., 2008a,b; Litvak et al., 2011) . Moreover, several reports indicate that, although the STN is the target of choice for surgical intervention therapies in PD, stimulation of the motor cortex also provides relief from symptoms (Pagni et al., 2003; Drouot et al., 2004; Lefaucheur et al., 2004) .
As stimulation parameters for DBS are similar to the "tetanizing" protocols used for the study of synaptic plasticity in many brain areas, we hypothesized that the beneficial effects of DBS arise, at least in part, as a consequence of the modulation of the efficacy of corticosubthalamic synapses and a reversal of the pathological effects of dopamine depletion. Indeed, dopamine depletion leads to the generation of large compound excitatory postsynaptic currents (EPSCs) in the STN (Ammari et al., 2011) , presumably as a consequence of a loss of inhibitory control of excitatory inputs by dopamine acting at presynaptic dopamine D2 receptors (Shen and Johnson, 2000) .
In this study, we have used high-frequency stimulation (HFS) of glutamatergic STN afferents to mimic DBS, and low-frequency stimulation (LFS) to mimic pathological bursting activity, in both dopamine-intact and chronically dopamine-depleted brain slices. We show that LFS increases the weight of glutamatergic synaptic inputs in dopamine intact tissue, whereas HFS elicits synaptic depression in dopamine-depleted tissue.
EXPERIMENTAL PROCEDURES
All the animals in this study were used in accordance with the Animals (Scientific Procedures) Act, 1986 (UK) and the European Communities Council Directive (80/609/ EEC).
Brain slice preparation
Parasagittal brain slices (300 μm thick) were prepared from young adult (45-52 days of age, 180-220 g) male Wistar rats. These animals were inbred from a colony originally obtained from Charles River (Kent, UK). Animals were first anaesthetized using isoflurane (2% in O 2 ) and decapitated. Slices were cut on a DTK-1000 Microslicer (Dosaka, Japan) in ice-cold sucrose-based solution containing (in mM) sucrose, 206; KCl, 2; MgSO 4 , 1.6; NaHCO 3 , 25.9; NaH 2 PO 4 , 1.25; glucose, 10; and CaCl 2 , 2.16. Slices were then transferred and incubated at room temperature for 1 h in artificial cerebrospinal fluid (aCSF) containing (in mM) NaCl, 126; KCl, 2.95; MgSO 4 , 1.6; NaHCO 3 , 25.9; NaH 2 PO 4 , 1.25; glucose, 10; CaCl 2 , 2; and ascorbic acid, 0.2. Both solutions were continuously aerated with 95% O 2 and 5%CO 2 , maintaining pH at 7.3 and 310 mOsm. Slices were then transferred to a recording chamber and perfused with aCSF at 34 °C at a rate of 2 ml min −1 . The whole STN and individual STN neurons were visualized by differential interference contrast (DIC) infrared microscopy using an Olympus BX51W1 microscope with a CCD camera (KP-M1; Hitachi, Tokyo, Japan).
Electrophysiology
Whole-cell voltage-clamp recordings were made using borosilicate glass pipettes (3-4 MÙ resistance). Electrodes were filled with an internal solution containing (in mM) HEPES, 40; QX-314, 5; EGTA, 0.6; NaCl, 4; D-gluconate, 100; TEA-Cl, 5; ATP-Na, 4; and GTP-Na, 0.3 (titrated with CsOH to pH 7.25) at 295 mOsm. The concentration of EGTA was set at 0.6 mM so as not to compromise potential plasticity involving calcium-dependent postsynaptic mechanisms. Synaptic currents were recorded at a holding potential of −60 mV using an Axopatch 200B amplifier (Molecular Devices Corp., Sunnyvale, CA, USA). Series resistance (range: 3-20 MÙ) was monitored throughout each experiment. Results from cells where series resistance changed over 20% or was >20 MÙ were discarded. The GABA A receptor channel blocker picrotoxin (50 μM) was present in the perfusate throughout all recordings. In experiments from dopamine-intact controls, the nonspecific dopamine receptor agonist apomorphine was bath applied at a concentration of 20 μM.
Stimulation protocols
Focal electrical stimulation was carried out using glass electrodes filled with normal aCSF. To evoke excitatory postsynaptic currents (eEPSCs) mediated by the cortico-subthalamic pathway, each stimulating electrode was placed in the rostral internal capsule, at a distance of at least 200 μm from the recorded STN cell. To assess the lasting effects of LFS and HFS, pairs of stimuli were delivered every 10 s, with an interstimulus interval of 50 ms. Stimulation was carried out via a DS-3 constant-current isolated stimulator (Digitimer Ltd., Welwyn Garden City, UK), and its parameters (amplitude and width) were adjusted on a cell-by-cell basis to produce 75% of maximum eEPSC amplitude. Stable baseline recordings were made for at least 10 min before HFS or LFS.
HFS consisting of 100 pulses at 100 Hz was chosen to mimic DBS. LFS was generated by delivering 40 Hz stimulation (10 pulses) every 1 s for 5 min. This latter paradigm mimics the pathological activity of STN neurons that emerges during the slow-wave activity brain state in anaesthetized 6-hydroxydopamine-lesioned rats (Magill et al., 2001) . HFS and LFS paradigms were programed in Clampex 10.2.
Data acquisition and analysis
Data were low-pass filtered at 2 kHz by an 8-pole Bessel filter (Axopatch 200B amplifier), and digitized at 10 kHz using a Digidata 1440A. Analysis was performed off-line using Clampfit 10.2 (Molecular Devices, Sunnyvale, CA, USA). Paired EPSCs (P1 and P2) were evoked by single-shock electrical stimulation of equal strength and duration, at an interstimulus interval of 50 ms and any changes in the paired pulse ratio (PPR) taken as indication of presynaptic locus of expression (Thomson, 2000) . PPRs were calculated by dividing the mean amplitude of second response (P2) by the mean amplitude of first response (P1), thus avoiding facilitatory bias (Kim and Alger, 2001) . Ten minutes of baseline (pre-LFS or HFS) data were compared with 10 min epochs of data throughout the duration of recording after LFS or HFS. Only data showing stable baseline amplitudes, defined as those having a coefficient of variation <0.15, were analyzed using one-way ANOVAs.
The interevent interval (IEI) of spontaneous EPSCs (sEPSCs) was analyzed off-line using Mini-Analysis Programe (Synaptosoft, USA). The significance of shifts in cumulative probability distributions was assessed using the Kolmogorov-Smirnov test (KS test). Ten minutes of data were compared with the number of events always being >100. To compare pooled data before and after stimulation, we determined median IEI values for each cell and calculated the mean of these median values for each cell population. All data are expressed as mean±SEM and significance for all statistical tests was set at P<0.05.
To confirm the locus of plasticity, coefficient of variation (CV) analysis was also undertaken (Bekkers and Stevens, 1990) . This is a form of nonstationary fluctuation analysis that allows synaptic characteristics to be determined when it is impractical to create conditions for altered release probability. Quantal theory describes changes in release probability (P) and number of release sites (N) at a presynaptic locus, whereas changes in response amplitude (Q) are postsynaptic. The mean amplitude of an EPSC represents the product of N, P, and Q, and the coefficient of variation (CV −2 ) is proportional to NP/1-P. Therefore, any presynaptic changes will affect CV −2 and be independent of Q. Thus, using a plot of mean amplitude (Q) against CV −2 , a response that moves along the x-axis indicates a postsynaptic locus of expression, whereas a response that moves along the diagonal indicates a presynaptic locus of expression.
6-hydroxydopamine lesions and behavioral testing
Unilateral 6-hydroxydopamine (6-OHDA) lesions were carried out on 150-180 g rats, as described previously (Magill et al., 2001) . Briefly, anesthesia was induced and maintained with isoflurane (1.5-2.5% in O 2 ). Twenty five minutes before the injection of 6-OHDA, all animals received a bolus of desipramine (25 mg kg −1 i.p.; Sigma) to minimize the uptake of 6-OHDA by noradrenergic neurons (Schwarting and Huston, 1997) . Immediately before use, the neurotoxin 6-OHDA (hydrochloride salt; Sigma) was dissolved in ice-cold 0.9% w/v NaCl solution containing 0.02% w/v ascorbate to a final concentration of 4 mg/ml. Three micro liters of 6-OHDA solution was then injected at a rate of 0.6 μl/min into the region adjacent to the medial substantia nigra (4.5 mm posterior of bregma, 1.2 mm lateral to the midline, and 7.9 mm ventral to the dura).
The extent of the dopamine cell lesion was assessed by the forelimb stepping test (Olsson et al., 1995) . Behavioral tests were performed 12 or 15 days after the injection of toxin. Each animal was tested twice per day for three consecutive days. Each of the animals used for electrophysiology showed significant deficits in forelimb stepping on the side contralateral to the lesion (ipsilateral 13.5±1.6 steps vs. contralateral 0.47±0.13 steps, n=10, P<0.0001). These observed behavioral changes indicate loss of the majority of dopamine neurons. Indeed, behavioral deficits of this magnitude not only correlate with significant reductions in tyrosine hydroxylase-expressing (dopaminergic) neurons but also with increased oscillatory activity in the BG (Tseng et al., 2005) . All electrophysiological recordings were performed 2-5 weeks after injection of toxin, which corresponds to a time when the pathophysiological state has stabilized at a maximum level (Pan and Walters, 1988; Vila et al., 2000) .
RESULTS
In the presence of picrotoxin (50 μM), stimulation within the internal capsule elicited a short-latency (monosynaptic) inward current that reversed around 0 mV and was blocked by glutamate receptor antagonists CNQX (10 μM) and D-AP5 (50 μM). At a stimulation frequency of 0.1 Hz, no potentiation or rundown of these synaptic responses and no changes in intrinsic properties such as resting membrane potential (monitored by changes in holding current) or input resistance were observed.
A previous study (Shen et al., 2003) indicated that the response of STN neurons to HFS was highly variable, such that potentiation, depression, or no changes were observed. We hypothesized that this could be owing to differing concentrations of dopamine release in STN within each brain slice (Cragg et al., 2004) , leading, in turn, to an inconsistent level of dopamine receptor activation. Therefore, in control experiments (slices from dopamineintact rats), we added the nonspecific dopamine receptor agonist apomorphine (20 μM) to the perfusate to mimic the "tonic" dopamine receptor activation that likely occurs locally in the STN in the intact brain (see Cragg et al., 2004) and provide maximum contrast between control slices and those slices obtained from 6-OHDA-lesioned animals. Addition of apomorphine (20 μM) elicited an inward current indicative of membrane depolarization, and an increase in input conductance, as previously observed after application of both receptor agonists and exogenous dopamine (Cragg et al., 2004; Loucif et al., 2008) . These postsynaptic effects were accompanied by a decrease in eEPSC amplitude consistent with previous observations. For each stimulation protocol, we assessed evoked (e)EPSC (P1) amplitudes and paired pulse ratios (P2/P1), and we performed a CV analysis of spontaneous (s)EPSCs.
In the first series of experiments, we examined the effect of HFS, consisting of 100 pulses at 100 Hz used to mimic DBS, on glutamatergic synaptic responses of STN neurons in slices from control (dopamine-intact) animals. No significant changes in P1 EPSP amplitude (104.4±8.0%, n=8 neurons, P>0.05, Fig. 1A, B ) or PPR (P2/P1, 0.87±0.09 and 0.87±0.07 at baseline and post-HFS, respectively, n=8, P>0.05, Fig. 1B, C) were observed after HFS. We next addressed the synaptic variability using CV analysis, which again yielded no evidence for changes in Q, N, or P (Fig. 1D ). Furthermore, no change in the IEI of sEPSCs was observed 20 min following HFS (P=0.8, KS test, Fig. 1E, F) . Therefore, in dopamine-intact slices and in the presence of dopamine receptor activation, HFS had no effect on the efficacy of the glutamatergic synapses.
We next examined the effect of HFS on glutamatergic synaptic responses of STN neurons in slices obtained from dopamine-depleted animals. In contrast to the scenario in slices from dopamine-intact animals, HFS of the cortico-subthalamic pathway in dopamine-depleted animals induced a short-term depression of P1 amplitude, lasting for approximately 2 min, followed by a longer lasting depression (67.8±6.2%, n=6, P<0.01 Fig. 2A, B) , which was recorded for at least 30 min. The depression of P1 following HFS was accompanied by a significant change in PPR (0.89±0.07 and 0.97±0.03 at baseline and post-HFS, respectively, n=6, P<0.05, Fig. 2B, C) . A significant presynaptic component was also evident in the CV analysis, which showed a pronounced movement along the diagonal toward origin that is indicative of a reduction in release probability and/or number of release sites (Fig. 2D) . These data correlated with the effect of HFS on sEPSCs because the IEI was significantly increased 20 min after stimulation, as compared with baseline (P<0.005, KS test, Fig. 2E , F). Thus HFS, which had no effect on excitatory inputs to STN neurons in dopamine-intact slices, produces a marked synaptic depression of glutamate responses after chronic dopamine depletion. This plasticity showed a clear presynaptic component in its locus of expression.
In a third series of experiments, we examined the effect of LFS (40 Hz stimulation, 10 pulses every 1 s for 5 min) to mimic the cortically driven bursting activity seen in the STN in vivo (Magill et al., 2001) . In dopamine-intact slices (with 20 μM apomorphine), LFS promoted a potentiation of P1 amplitude for the following 30 min (126.4±8.1%, n=7, P<0.01, Fig. 3A, B) . Although no significant changes in PPR were observed (0.79±0.1 and 0.75±0.06 at baseline and post-LFS, respectively, n=7, P>0.05, Fig. 3B, C) , analysis of CV showed movement along the diagonal away from the origin indicative of increases in either probability of release and/or number of release sites (Fig. 3D) , that is, in the opposite direction from changes observed after HFS in dopamine-depleted slices. These data correlated with analysis of sEPSC and a decrease in IEI (increase in frequency) 20 min after LFS (P<0.05, KS test, Fig. 3E, F) . Therefore, in contrast to HFS, LFS in dopamine-intact slices produces a marked potentiation in synaptic weight of glutamatergic synapses, which also showed a presynaptic locus of expression.
Finally, we examined the effect of LFS on glutamatergic synaptic responses of STN neurons in slices obtained from dopamine-depleted animals. In this case, LFS induced a short-lived depression that immediately followed the stimulation protocol, but no significant longerlasting changes in P1 amplitude were observed (106.7±10.0%, n=6, P>0.05, Fig. 4A, B ). There was also no significant change in PPR (0.97±0.09 and 1.01±0.08 at baseline and post-LFS, respectively, P>0.05 Fig. 4B, C) . There was a small change in CV along the diagonal (Fig. 4D ), but this was not associated with amplitude changes in P1, PPR, and IEI of sEPSCs (P>0.05, KS test, Fig. 4E, F) . Therefore, the significant potentiation of glutamatergic EPSCs induced by LFS in dopamine-intact slices is not replicated in slices obtained from dopamine-depleted animals.
DISCUSSION
We have shown that LFS, which mimics pathological cortically driven bursting activity in STN, promoted potentiation of glutamatergic (cortico-subthalamic) synaptic inputs but only in dopamine-intact tissue. Similarly, HFS promotes synaptic depression but only in dopamine-depleted tissue, indicating that the beneficial effects of DBS may be mediated, in part, by depression of cortico-subthalamic synapses (Fig. 5 ). Taken together, these results suggest that the synaptic weight of the cortico-subthalamic pathway is dynamically modulated by ambient concentrations of dopamine, such that it is reduced in dopamineintact animals and increased in the dopamine-depleted Parkinsonian state. We propose that the increase in the relative weight of cortico-subthalamic synapses in the Parkinsonian animal is one way by which the STN becomes sensitized to oscillatory cortical inputs, resulting in increased pathological bursting activity in STN that is coherent with cortical activity (Magill et al., 2001; Sharott et al., 2005; Mallet et al., 2008a,b) .
Experimental considerations
The STN contains a relatively homogenous population of glutamatergic projection neurons (Nakanishi et al., 1987; Beurrier et al., 1999; Bevan et al., 2002; Loucif et al., 2008) . It receives extensive, topographically organized inputs from ipsilateral frontal neocortex, including motor and premotor areas (Smith et al., 1998; Nambu et al., 2000) . Afferent inputs arising in these cortical areas have a powerful synchronizing effect on ensembles of STN neurons (Magill et al., 2004) , and provide a good substrate for the entrainment of STN firing to ongoing cortical oscillations (Magill et al., 2000 (Magill et al., , 2001 Mallet et al., 2008a,b) .
Unfortunately, the synaptic weight of cortico-subthalamic inputs cannot be directly tested by simply measuring basal synaptic transmission in control and dopamine-depleted slices. This would require that the cortex is the only source of glutamatergic input to STN. This is not the case as glutamatergic neurons of the intralaminar thalamus and mesopontine tegmentum also innervate the STN . One would also have to assume that these inputs are unaffected by dopamine-depletion. However, given that the cortex provides the majority of the glutamatergic inputs to STN that course through the internal capsule (Kitai and Deniau, 1981; Nambu et al., 2000) , we assume that our electrical stimuli evoked glutamate release from cortically derived axon terminals. We have only assessed spontaneous EPSCs because assessment of miniature EPSCs in the presence of tetrodotoxin, the usual strategy for determination of presynaptic versus postsynaptic effects, is not compatible with HFS and LFS. We acknowledge that data relating to changes in sEPSC frequency alone cannot be used to definitely determine locus of action. However, changes in sEPSC frequency, without changes in holding potential or input resistance, combined with paired pulse and CV data provides ample evidence for a presynaptic component of plasticity.
STN neurons recorded in vivo from 6-OHDA-lesioned animals display a 2-3-fold increase in the magnitude of their bursting activity in time with the cortex as compared with STN neurons in dopamine-intact controls (Magill et al., 2001) . This abnormal bursting during slow-wave sleep may also lead to the reinforcement of synaptic weights, particularly along the cortico-subthalamic pathway. The LFS protocol utilized in this study mimics this pathological, slow busting activity, whereas HFS at 100 Hz mimics DBS. We acknowledge that longer duration HFS may produce more robust plastic changes, and that this may be viewed more analogous to DBS. However, as short duration stimulations were sufficient to induce plasticity, and longer duration stimulations compromise cell viability, the stimulation protocols employed here allow extended good-quality recordings and tests of plasticity, while relating to the protocols used clinically. Indeed, both LFS and HFS employed here are similar to those used in many other synaptic plasticity studies both in vitro and in vivo.
Mechanism of DBS
As the beneficial effects of DBS targeted to the STN were similar to STN lesions, the mechanism originally proposed for DBS efficacy involved functional inhibition of the STN, including through depolarization block and/or functional deafferentation (Benazzouz et al., 1993; Benazzouz and Hallett, 2000) . More recently, multiple effects of DBS have been described including local changes in neuronal excitability, enhanced GABA and glutamate release, axonal activation and axonal block (see Deniau et al., 2010 for review) as well as stimulus induced modulation of pathological activity (Hammond et al., 2008) .
The fact that lesions of the STN have beneficial effects in animal models of PD, and that the behavioral effects of HFS were similar to those of lesions, led to the STN being the preferred site of stimulation (Benazzouz et al., 1993; Krack et al., 2003) . However, this does not necessarily establish a leading role for the STN in generating all pathological activity in Parkinsonism. Indeed there is an argument that the STN is an efficacious site of stimulation because of its small volume and nodal point within BG circuitry. Recent evidence has implicated the cortex not only in the generation of pathological activity but also as a potential target both for pharmacological and surgical interventions in modulating such activity. Thus, HFS of cortex appears to normalize firing rates in the Parkinsonian STN and reduce akinesia and bradykinesia Pagni et al., 2005) . Furthermore, repetitive transcranial magnetic stimulation improves motor performance in PD (Siebner et al., 2000; Khedr et al., 2003; Lefaucheur et al., 2004; Fregni et al., 2006) . These findings are supplemented by reports that DBS of the STN promotes antidromic stimulation of cortical networks implicated in the generation of pathological oscillations in PD (Li et al., 2007; Lehmkuhle et al., 2009) , with the magnitude of antidromic activation correlating with the suppression of pathological beta activity. In addition, any antidromic (and thence, orthodromic) activation of neuronal networks within the cortex would directly modulate and perhaps negate the oscillatory activity being transferred from cortex to STN. However, one of the most compelling pieces of evidence implicating the cortico-subthalamic pathway in the beneficial effects of HFS is a recent optogenetic study that allowed the precise role of different nuclei and axonal projections to be determined in behaving Parkinsonian rodents. Thus, the therapeutic effects of DBS were only accounted for by direct stimulation of afferents projecting to the STN, and specifically, those arising from layer V cortical neurons, again implicating the cortico-subthalamic pathway (Gradinaru et al., 2009 ).
The frequency-and dopamine-dependency of changes in the plasticity profile of the corticosubthalamic pathway presented here add further to the weight of evidence that this pathway plays a central role in PD pathology. Low-frequency stimulation potentiated glutamatergic (cortico-subthalamic) synaptic inputs in dopamine-intact tissue only, and HFS promoted synaptic depression in dopamine-depleted tissue only, suggesting that the synaptic weight of the cortico-subthalamic pathway is dynamically modulated by dopamine. Furthermore, these results further promote the view that the beneficial effects of DBS are at least in part owing to stimulation of the cortico-subthalamic pathway.
Synaptic plasticity
Although motor symptoms of PD reappear within seconds/minutes after DBS ceases (Temeperli et al., 2003) , several pieces of evidence indicate a mechanistic role for synaptic plasticity in the therapeutic effects of DBS. The maximum benefits on tremor and rigidity are reached with a delay of minutes after the switching on of DBS, whereas the delay in reaching maximum benefit for akinesia may be minutes to hours (Krack et al., 2002) . Furthermore, it is often necessary to adjust and refine stimulus parameters over the lifetime of DBS therapy (Krack et al., 2002) , indicating some slowly evolving synaptic or other change associated with disease progression. Moreover, it has long been recognized that the stimulation frequency is the key to determining clinical efficacy in Parkinsonism. When DBS is directed to the STN, clinical benefits become evident at stimulation frequencies above 50 Hz, whereas stimulation at lower frequencies (5-20 Hz) exacerbates the symptoms of rigidity and bradykinesia (Moro et al., 2002; Fogelson et al., 2005; Eusebio et al., 2008) .
With regard to movement disorders, plasticity in the cortico-striatal pathway has been studied extensively (Calabresi et al., 1992 (Calabresi et al., , 1997 (Calabresi et al., , 2000 see Kreitzer and Malenka, 2008 for review) . In response to high-frequency stimulation (HFS-trains of pulses at 100 Hz), the glutamatergic cortico-striatal synapses undergo either long-term potentiation (LTP) or longterm depression (LTD), with dopaminergic signaling necessary for the induction of such plasticity (Calabresi et al., 1997; Kreitzer and Malenka, 2005) . However, Shen et al. (2008) reported that dopamine is not necessarily required for the induction of synaptic plasticity, but it is critical for the bidirectional, spike timing-dependent plasticity. Dopamine, acting in concert with other neurotransmitters and neuromodulators, such as glutamate, adenosine, and cannabinoids, displays concentration-dependent actions at D1 and D2 receptors that determine the direction of plasticity. Our data show that this is also the case with the corticosubthalamic pathway, where chronic depletion of dopamine does not eliminate plasticity, but rather, determines the plasticity profile in response to different stimulation protocols. As acute administration of dopamine antagonists does not replicate the chronic changes in oscillatory dynamics associated with dopamine deletion, (Mallet et al., 2008b) and the presence (or absence) of dopamine may only play a role in the induction of plasticity, we have not attempted to reverse the synaptic depression associated with HFS by acute administration of the dopamine agonist apomorphine.
With the exception of one published report (Shen et al., 2003) , stimulus-induced long-term adaptations in the synaptic weight of glutamatergic inputs to the STN have not been studied. However, Shen et al. (2003) showed that HFS (100 Hz for 1 min) of inputs to STN induces three forms of synaptic plasticity at glutamatergic synapses, including short-term potentiation (STP), LTP, and LTD. The STP and the LTD have paired-pulse characteristics that are consistent with changes in presynaptic action, whereas the characteristics of the LTP are more consistent with a postsynaptic action. Although we do not rule out a postsynaptic locus for some forms of synaptic plasticity in STN, the potentiation and depression of the cortico-subthalamic pathway induced by LFS and HFS, respectively, that we define here have presynaptic components that relate to changes in the probability of release or the number of release sites. Furthermore, synaptic depression induced by HFS only occurs in the dopamine-depleted state. Consistent with these findings, EPSCs in STN in dopaminedepleted animals are amplified and followed by bursts of polysynaptic EPSCs, both of which are attenuated by HFS (Ammari et al., 2011) .
Effect on pathological oscillations
Synchronized beta-frequency oscillations in the cortex and BG structures (including STN) are considered pathological because not only do they correlate with rigidity and bradykinesia but also because both beta activity and symptoms are simultaneously suppressed by dopamine replacement (Priori et al., 2004; Kühn et al., 2006 Kühn et al., , 2009 or DBS (Gaynor et al., 2008; Eusebio et al., 2011) . This excessive synchronization of activity is accompanied by increased coherence across cortico-basal ganglia networks and is thought to limit computational capacity through reduced information coding capacity (see Hammond et al., 2007) .
In this study, we show that, in dopamine-intact tissue, LFS increases the weight of glutamatergic synaptic inputs and that, in the dopamine-depleted state, the beneficial effects of HFS are consistent with synaptic depression. As HFS reduces glutamate input and DBS reduces beta oscillations and motor symptoms, then beta activity and other pathological changes might be supported by cortico-subthalamic input that is abnormally strengthened after dopamine loss. Further support for this idea can be found in a recent computational modeling study (Moran et al., 2011) . The increase in the relative weight of corticosubthalamic synapses is therefore one way by which the STN becomes sensitized to oscillatory cortical inputs, resulting in increased pathological bursting activity that is coherent with cortical activity. As the cortex appears to play a critical role in manifestation of pathological oscillations, it provides an alternative, less invasive site of stimulation, which still requires optimum stimulation paradigms to be determined for best symptomatic relief. This figure illustrates the potential increase in synaptic weight of cortico-subthalamic input promoted by the depletion of dopamine, the definitive pathology in Parkinson's disease. High-frequency stimulation (HFS) of glutamatergic inputs to STN, which mimics deep brain stimulation (DBS), has no effect in dopamine-intact slices but elicits synaptic depression in dopamine-depleted slices. In contrast, low-frequency stimulation (LFS), which mimics pathological bursting, has no effect in dopamine-depleted but elicits synaptic potentiation in the dopamine-intact slices. 
